UBS Group’s IDEX Biometrics ASA American Depositary Shares IDBA Stock Holding History

UBS Group’s Portfolio IDBA Stock Details IDBA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,616	Closed	-$13.1K	–	11077
2022 Q4	$13.1K	Buy	1,616 +527	+48%	+$4.08K	﹤0.01%	8203
2022 Q3	$6K	Buy	1,089 +699	+179%	+$5.2K	﹤0.01%	9121
2022 Q2	$4K	Buy	390 +100	+34%	+$1.18K	﹤0.01%	9206
2022 Q1	$5K	Buy	+290	New	+$5.43K	﹤0.01%	9212
2021 Q4	–	Sell	-62	Closed	-$1K	–	10985
2021 Q3	$1K	Buy	+62	New	+$1.23K	﹤0.01%	9332

Other funds holding IDBA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's IDBA Position: Q1 2023 in Review

UBS Group sold out of IDEX Biometrics ASA American Depositary Shares (IDBA) in Q1 2023, closing a stake of 1,616 shares — an estimated $13.1K sold.

UBS Group first reported a position in IDBA in Q3 2021 and held it in 5 quarters. The position peaked at $13.1K in Q4 2022. 1 fund tracked by Wall St. Rank holds IDBA as of Q1 2023.

UBS Group reported no remaining IDEX Biometrics ASA American Depositary Shares position as of Q1 2023 after selling out during the quarter.
UBS Group sold 1,616 IDEX Biometrics ASA American Depositary Shares shares in Q1 2023, an estimated $13.1K.
UBS Group first reported a position in IDEX Biometrics ASA American Depositary Shares in Q3 2021 and held it in 5 quarters.
UBS Group's IDEX Biometrics ASA American Depositary Shares position peaked at $13.1K in Q4 2022.
1 fund tracked by Wall St. Rank held IDEX Biometrics ASA American Depositary Shares as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.